Is your startup facing sluggish traction & investor brick wall?

Your innovation may not be the issue; it is often due to asset mis-positioning.

our philosophy

Innovation & clinical approval don’t guarantee adoption.

What’s the “so-what” of your solution?

Having an innovative breakthrough (and approval if used in a clinical setting) is just the admission ticket.

For a solution to demonstrate value, it needs to solve pain points precisely where they are felt most acutely, in a way that would generate the most sustainable and scalable commercial traction.

“So-what” and “who pays” go hand-in-hand.

our methodology

01 - vertical

Stakeholder Alignment

Analyze stakeholder KPIs and Identify ones that the unmet need affects most and will pay.

(Many clinical innovations benefit physicians and patients, but adoption is ultimately determined by payors/procurement teams.)

We help life sciences startups with asset positioning & GTM with our three-axis, business-first, positioning approach.

02 - horizontal

Landscape & Defensibility

Map competitive dynamics and macro tailwind or headwind.

Confirm that your solution is addressing a high-value growing pain, instead of a problem that will become obsolete or absorbed in the near term.

03 - depth

Commercial Architecture

Based on the revised positioning, we design the business model, go-to-market strategy, and milestone schedule.

We help you generate the data and traction to prove your commercial utility to the market.

case studies

  • BEFORE

    Clinically approved cancer risk test marketed as mass-market health check screening test – struggled with commercial traction since launch.

    AFTER

    Positioned as a B2B clinical eligibility gate, unlocking revenue and securing strategic distribution contracts in the HNW private sector.

  • BEFORE

    Biotech asset that faced regulatory barrier. Forced to sell as an OTC product in a highly competitive space in secondary markets, resulting in unnecessarily high burn and low sales.

    AFTER

    Surgical suite infection prevention solution. Leveraged existing local strategic partnerships to create a low-cost pilot, generating market confidence.

You’ve built something clinically impactful; we help you find where it actually wins.

Commercial architecture built around a scientific asset’s true value.

A professional headshot of a man wearing glasses, a dark suit, a light-colored shirt, and a patterned tie, against a yellow background with a white outline around his face.

Building bottom-up in a commercial vacuum leads to a predictable cycle: sluggish traction, market rejection, and exhausted capital. At mustardseed, we bring a proven top-down perspective to fix your alignment before that happens. We build a viable business first, leveraging real market traction to put you in the strongest position for fundraising and potential exit.

Let’s begin the conversation.

Stalled at the commercial gate? We can help. Every scientific asset has a unique point of maximum market leverage. If you are questioning your current trajectory, let’s find the answers. Contact us with your pipeline constraints, or if you're ready to realign your strategy, schedule an initial evaluation today.

Text reading 'mustard seed' with a small yellow dot. 
© 2026 by mustardseed. life sciences Ltd.
All rights reserved.